(GILD) Gilead Sciences - Performance 69.5% in 12m
Compare GILD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
64.45%
#8 in Group
Rel. Strength
93.22%
#542 in Universe
Total Return 12m
69.54%
#22 in Group
Total Return 5y
62.47%
#27 in Group
P/E 275
95th Percentile in Group
P/E Forward 13.2
46th Percentile in Group
PEG 0.22
67th Percentile in Group
FCF Yield 7.12%
98th Percentile in Group
12m Total Return: GILD (69.5%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: GILD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GILD
Total Return (including Dividends) | GILD | XBI | S&P 500 |
---|---|---|---|
1 Month | -4.92% | 2.28% | -0.87% |
3 Months | 10.38% | -10.48% | -7.58% |
12 Months | 69.54% | -1.83% | 11.88% |
5 Years | 62.47% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | GILD | XBI | S&P 500 |
1 Month | -30.4% | 56.6% | 23% |
3 Months | 11.7% | -89.3% | -88.5% |
12 Months | 97.1% | -42.4% | 55.1% |
5 Years | 79.3% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #143 | -7.04% | -4.09% |
3 Month | #28 | 23.3% | 19.4% |
12 Month | #22 | 72.7% | 51.5% |
5 Years | #29 | 86.2% | -22.8% |
FAQs
Does GILD Gilead Sciences outperforms the market?
Yes,
over the last 12 months GILD made 69.54%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months GILD made 10.38%, while XBI made -10.48%.
Over the last 3 months GILD made 10.38%, while XBI made -10.48%.
Performance Comparison GILD vs Indeces and Sectors
GILD vs. Indices GILD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.42% | -4.05% | 23.7% | 57.7% |
US NASDAQ 100 | QQQ | -4.45% | -6.32% | 23.2% | 56.9% |
US Dow Jones Industrial 30 | DIA | -2.48% | -1.74% | 23.8% | 60.3% |
German DAX 40 | DAX | -2.19% | -6.24% | 4.15% | 44.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.54% | -2.10% | 26.7% | 63.6% |
Hongkong Hang Seng | HSI | -2.43% | -4.98% | 21.8% | 55.7% |
India NIFTY 50 | INDA | -0.58% | -8.98% | 23.4% | 66.5% |
Brasil Bovespa | EWZ | -2.62% | -9.52% | 20.0% | 75.4% |
GILD vs. Sectors GILD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.67% | -3.87% | 17.5% | 45.6% |
Consumer Discretionary | XLY | -3.50% | -4.82% | 21.2% | 56.2% |
Consumer Staples | XLP | 0.08% | -5.12% | 18.4% | 58.3% |
Energy | XLE | 1.06% | 8.94% | 29.5% | 80.6% |
Financial | XLF | -2.03% | -2.81% | 16.1% | 46.9% |
Health Care | XLV | -3.34% | -1.13% | 25.4% | 67.8% |
Industrial | XLI | -3.84% | -5.03% | 23.0% | 60.0% |
Materials | XLB | -2.81% | -2.49% | 31.1% | 73.1% |
Real Estate | XLRE | -1.90% | -3.61% | 24.6% | 51.5% |
Technology | XLK | -5.87% | -6.61% | 27.0% | 61.8% |
Utilities | XLU | -0.58% | -4.98% | 21.6% | 47.7% |
Aerospace & Defense | XAR | -4.37% | -11.3% | 10.1% | 43.0% |
Biotech | XBI | -4.72% | -7.20% | 36.3% | 71.4% |
Homebuilder | XHB | -2.73% | -2.65% | 38.5% | 76.6% |
Retail | XRT | -1.85% | -4.36% | 29.2% | 72.3% |